Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Management changes at XOMA

This article was originally published in Scrip

Executive Summary

Steve Engle, XOMA's chief executive officer, president and chairman has resigned from the company after four years' service. John Varian, a current board member and former COO and CFO of Aryx Therapeutics, will take over as interim CEO during the search for a permanent CEO, and W Denman Van Ness, XOMA's lead independent director, has been elected chairman.

Advertisement
Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC014291

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel